Penny stock below Rs 50 jumps over 10 per cent as pharma company bags new order worth USD 17,700 from Al-Saqr Agro For Agricultural And Veterinary Entries

The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent.

Shelter Pharma Limited has secured a significant international order from Al-Saqr Agro For Agricultural And Veterinary Entries in Yemen. The order is for Super Vltamas Feed Supplements valued at USD 17,700. The terms of the contract include a 100 per cent advance payment, CNF pricing, and a two-month delivery timeline. The specific products ordered are Super Vltamas Feed Supplements in 1kg, 10kg and 20kg quantities. The total order breakdown is 1,000 units of 1kg, 200 units of 10kg and 400 units of 20kg. The pricing for each quantity is USD 1.5 per unit for 1kg, USD 17 per unit for 10kg and USD 32 per unit for 20kg.

Shelter Pharma Limited is a prominent pharmaceutical and nutraceutical company renowned for its dedication to research, innovation and quality. Established to provide accessible and effective healthcare solutions, the company has consistently delivered products that meet the highest industry standards. Their state-of-the-art facilities, world-class team of experts and commitment to ethical practices have earned them a reputation of trust in the industry. Shelter Pharma's mission is to promote well-being and health through innovative, high-quality nutraceuticals.

On Wednesday, shares of Shelter Pharma Ltd jumped over 10 per cent to an intraday high of Rs 48.70 per share from its previous closing of Rs 43.99 per share with a spurt in volume by more than 1.01 times on BSE. The stock’s 52-week high is Rs 80.90 and its 52-week low is Rs 37.50. The stock falls under S&P BSE SME IPO with a lot size of 3,000 shares.

The company has a market cap of over Rs 50 crore. The company’s current debt is Rs 0.57 crore which is less than 1 per cent of the market cap. The promoters own more than half of the company's shares, with 56.89 per cent while the general public owns the rest, with 43.11 per cent as of March 2024. There are 868 public shareholders as of March 2024.

The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent. The stock is up 30 per cent from its 52-week low of Rs 37.50 per share.

Disclaimer: The article is for informational purposes only and not investment advice.